Thus, despite the high degree of homology between the carboxyl-terminal sequences of MAP2 and Tau (see Figure 1), they have differential fates the course of in NFT formation; that is, MAP2 does not deposit aggressively like Tau and is lost from NFT-forming cells in the AD brain. The gene discussed is MAPT; the disease is Alzheimer disease.